Vaccinex Delivers Virtual Presentation at the Advances in Alzheimer’s and Parkinson’s Therapies AAT-AD/PD™ Focus Meeting 2020
Vaccinex, Inc. (VCNX)
Company Research
Source: GlobeNewswire
ROCHESTER, N.Y., April 07, 2020 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in cancer and neurodegenerative diseases, today announced that the company’s vice president of preclinical research, Elizabeth Evans, Ph.D, delivered a virtual presentation at the Alzheimer’s and Parkinson’s Therapies AAT-AD/PD™ Focus Meeting 2020, which was held from April 2-5. The presentation, entitled, “Regulation of Glial Cell Activation and Neurodegeneration by Anti-Semaphorin 4D Antibody Pepinemab, Potential Treatment for Alzheimer’s and Huntington’s Disease,” summarizes compelling findings from 19 patients enrolled in the company’s ongoing SIGNAL Phase 2 trial of pepinemab for the treatment of Huntington’s disease. “Our presentation at this important meeting underscores the potential of pepinemab as a new therapeutic option for neurodegenerative diseases, notably Huntington’s and Alzheimer’s, t
Show less
Read more
Impact Snapshot
Event Time:
VCNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCNX alerts
High impacting Vaccinex, Inc. news events
Weekly update
A roundup of the hottest topics
VCNX
News
- Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]Yahoo! Finance
- Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq RulesGlobeNewswire
- Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology [Yahoo! Finance]Yahoo! Finance
- Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus TechnologyGlobeNewswire
- Vaccinex, Inc. Announces Reverse Stock Split [Yahoo! Finance]Yahoo! Finance
VCNX
Sec Filings
- 3/27/24 - Form 8-K
- 3/22/24 - Form 4
- 3/22/24 - Form 4
- VCNX's page on the SEC website